New York, NYCIK 20119326 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
53 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Praxis Precision Medicines I | 58.1K | $17.13M | 8.5% | −43.9K | Reduced |
| 2 | Cogent Biosciences Inc | 305.6K | $10.85M | 5.4% | −138.0K | Reduced |
| 3 | Guardant Health Inc | 98.2K | $10.03M | 5.0% | 0 | Held |
| 4 |
| 116.5K |
| $9.22M |
| 4.6% |
| −14.5K |
| Reduced |
| 5 | Eli Lilly & Co | 7.9K | $8.44M | 4.2% | 0 | Held |
| 6 | Cytokinetics Inc | 124.7K | $7.93M | 3.9% | −17.7K | Reduced |
| 7 | Wave Life Sciences Ltd | 421.5K | $7.17M | 3.5% | +421.5K | New |
| 8 | Vera Therapeutics Inc | 124.4K | $6.30M | 3.1% | −31.7K | Reduced |
| 9 | Bridgebio Pharma Inc | 80.7K | $6.17M | 3.1% | −52.4K | Reduced |
| 10 | Elevance Health Inc | 17.2K | $6.03M | 3.0% | +17.2K | New |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio